Novavax to Participate in Jefferies London Healthcare Conference

Rhea-AI Summary

Novavax, Inc. (Nasdaq: NVAX) to Participate in Jefferies London Healthcare Conference, Fireside Chat with CEO and President, Investor Meetings, and Recorded Session Available

GAITHERSBURG, Md., Nov. 10, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the Jefferies London Healthcare Conference.

Conference Details:
Fireside Chat
Date:		Wednesday, November 15, 2023
Time:		9:00 – 9:25 a.m. Greenwich Mean Time (GMT)
Location:		London
Moderator:		Roger Song, M.D., CFA, Equity Analyst
Novavax participants:		John C. Jacobs, President and Chief Executive Officer and Filip Dubovsky, M.D., President, Research & Development
Conference
Event:		Investor Meetings
Date:		Wednesday, November 15, 2023

Recordings
A replay of the recorded fireside session will be available through the Events & presentations page of the Company's website at ir.novavax.com for 45 days from the date of the conference.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza and COVID-19 and influenza combined. Please visit novavax.com and LinkedIn for more information.

Please visit novavax.com and LinkedIn for more information.

Contacts: 
Investors
Erika Schultz
240-268-2022
ir@novavax.com 

Media
Ali Chartan
240-720-7804
media@novavax.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-jefferies-london-healthcare-conference-301984205.html

SOURCE NOVAVAX, INC

FAQ

What event is Novavax participating in?

Novavax is participating in the Jefferies London Healthcare Conference, including a fireside chat and investor meetings.

Who will be participating from Novavax?

John C. Jacobs, President and Chief Executive Officer, and Filip Dubovsky, M.D., President, Research & Development will be participating.

Where can the recorded session be accessed?

The recorded fireside session will be available for 45 days from the date of the conference on Novavax's website at ir.novavax.com.